STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Company

Vir Biotechnology, Inc.

Filed

July 6, 2021

Period of Report

July 1, 2021

Accession Number

0001062993-21-006362